YDESW YD Bio Limited

Fundamentals / CIK 0002011674 / USD
Other share classes on CIK 0002011674: YDES

YD Bio Limited reported $597K in revenue and a net loss of $8.31M for the fiscal year ended December 31, 2025 (up 16.9% year over year), with a 28.1% gross margin and a -883.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open YDESW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$1.47M$733K$0-$7.82MFY 2023 Revenue: $350KFY 2023 Net Income: $14K2023FY 2024 Revenue: $510KFY 2024 Net Income: -$1.41M2024FY 2025 Revenue: $597KFY 2025 Net Income: -$8.31M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $597K $510K $350K
Cost of Revenue $429K $355K $197K
Gross Profit $167K $155K $153K
Research & Development $1.60M $491K --
Selling, General & Admin $3.83M $1.13M $161K
Total Operating Expenses $5.44M $1.62M $163K
Operating Income -$5.27M -$1.46M -$9.8K
EBITDA -$5.06M -$1.36M -$7.4K
Interest Income $80K $12K $290
Interest Expense -- $772 $2.1K
Income Before Tax -$8.31M -$1.39M $18K
Income Tax Expense -$1.5K $25K $4.1K
Net Income -$8.31M -$1.41M $14K
Basic EPS -$0.12 -$0.02 $0.00
Diluted EPS -$0.12 -$0.02 $0.00
Basic Shares Outstanding 66.7M 64.7M 64.7M
Diluted Shares Outstanding 66.7M 64.7M 64.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for YDESW.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $6.01M $3.13M
Cash & Short-Term Investments $6.01M $3.13M
Accounts Receivable, Net $167K $87K
Inventory $1.88M $37K
Total Current Assets $9.67M $3.47M
Property, Plant & Equipment, Net $59K $64K
Intangible Assets $2.61M $2.68M
Total Non-Current Assets $4.11M $3.40M
Total Assets $13.78M $6.86M
Accounts Payable $413K $27K
Deferred Revenue (Current) $30K $28K
Total Current Liabilities $1.64M $263K
Long-Term Debt $6.8K --
Total Non-Current Liabilities $14.99M $11K
Total Liabilities $16.64M $274K
Total Debt (incl. Leases) $14K $22K
Common Stock $7.1K $6.5K
Retained Earnings -$10.24M -$1.93M
Accumulated Other Comp. Income $214K $45K
Total Stockholders' Equity -$2.86M $6.59M
Total Equity -$2.86M $6.59M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31
Cash & Cash Equivalents $6.01M $3.13M
Cash & Short-Term Investments $6.01M $3.13M
Accounts Receivable, Net $167K $87K
Inventory $1.88M $37K
Total Current Assets $9.67M $3.47M
Property, Plant & Equipment, Net $59K $64K
Intangible Assets $2.61M $2.68M
Total Non-Current Assets $4.11M $3.40M
Total Assets $13.78M $6.86M
Accounts Payable $413K $27K
Deferred Revenue (Current) $30K $28K
Total Current Liabilities $1.64M $263K
Long-Term Debt $6.8K --
Total Non-Current Liabilities $14.99M $11K
Total Liabilities $16.64M $274K
Total Debt (incl. Leases) $14K $22K
Common Stock $7.1K $6.5K
Retained Earnings -$10.24M -$1.93M
Accumulated Other Comp. Income $214K $45K
Total Stockholders' Equity -$2.86M $6.59M
Total Equity -$2.86M $6.59M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$8.31M -$1.41M $14K
Depreciation & Amortization $210K $105K $2.5K
Change in Receivables -$84K $6.3K -$64K
Change in Inventory -$1.84M $29K -$31K
Operating Cash Flow -$6.60M -$1.22M -$56K
Capital Expenditure -$1.44M -$75K -$290
Free Cash Flow -$8.04M -$1.30M -$56K
Investing Cash Flow -$1.44M -$2.90M -$290
Common Stock Issued $13.20M $7.55M --
Financing Cash Flow $10.87M $7.11M $114K
Net Change in Cash $2.88M $3.05M $57K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for YDESW.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Gross Margin 28.1% 30.4% 43.8%
Operating Margin -883.3% -286.5% -2.8%
Net Profit Margin -1392.6% -276.6% 3.9%
Return on Equity (ROE) -- -21.4% --
Return on Assets (ROA) -60.3% -20.6% --
Current Ratio 5.88x 13.18x --
Quick Ratio 4.74x 13.04x --
Debt to Equity -- 0.00x --
Revenue Growth (YoY) +16.9% +45.8% --
Gross Profit Growth (YoY) +7.8% +1.2% --
Net Income Growth (YoY) -- -10509.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for YDESW.
Source: SEC EDGAR CompanyFacts (CIK 0002011674) · from December 31, 2023 Data through December 31, 2025 · synced Nov 20, 2026, 05:37 UTC · Open in terminal